Publication | Closed Access

Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy

InflammationBiomarker (Medicine)Prognostic BiomarkersMedicinePrognostic ValueImmunologyAdvanced Nsclc PatientsBiomarkersInflammatory MarkerImmunotherapyOncologyInflammatory Response BiomarkersRadiology